DICE Therapeutics, Inc. Quarterly Depreciation in USD from Q1 2021 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
DICE Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from Q1 2021 to Q1 2023.
  • DICE Therapeutics, Inc. Depreciation for the quarter ending March 31, 2023 was $244K, a 61.6% increase year-over-year.
  • DICE Therapeutics, Inc. annual Depreciation for 2022 was $825K, a 24.8% increase from 2021.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $244K +$93K +61.6% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q1 2022 $151K -$29K -16.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q1 2021 $180K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.